Experimental Cancer Drug Sees 100% Success Rate In Clinical Trial
A small clinical trial testing the experimental drug dostarlimab saw 100% of rectal cancer cases go into remission, with oncologists saying the unprecedented results have the potential of being a huge step forward in cancer research. What do you think?
Gideon Morris
I don't know, my HMO says there are a lot of upsides to having cancer.
Dirt Expert